Clostridioides difficile Toxin CDT Induces Cytotoxic Responses in Human Mucosal-Associated Invariant T (MAIT) Cells

Clostridioides difficile is the major cause of antibiotic-associated colitis (CDAC) with increasing prevalence in morbidity and mortality. Severity of CDAC has been attributed to hypervirulent C. difficile strains, which in addition to toxin A and B (TcdA, TcdB) produce the binary toxin C. difficile transferase (CDT). However, the link between these toxins and host immune responses as potential drivers of immunopathology are still incompletely understood. Here, we provide first experimental evidence that C. difficile toxins efficiently activate human mucosal-associated invariant T (MAIT) cells. Among the tested toxins, CDT and more specifically, the substrate binding and pore-forming subunit CDTb provoked significant MAIT cell activation resulting in selective MAIT cell degranulation of the lytic granule components perforin and granzyme B. CDT-induced MAIT cell responses required accessory immune cells, and we suggest monocytes as a potential CDT target cell population. Within the peripheral blood mononuclear cell fraction, we found increased IL-18 levels following CDT stimulation and MAIT cell response was indeed partly dependent on this cytokine. Surprisingly, CDT-induced MAIT cell activation was found to be partially MR1-dependent, although bacterial-derived metabolite antigens were absent. However, the role of antigen presentation in this process was not analyzed here and needs to be validated in future studies. Thus, MR1-dependent induction of MAIT cell cytotoxicity might be instrumental for hypervirulent C. difficile to overcome cellular barriers and may contribute to pathophysiology of CDAC.

[1]  A. Pich,et al.  The Binary Toxin of Clostridioides difficile Alters the Proteome and Phosphoproteome of HEp-2 Cells , 2021, Frontiers in Microbiology.

[2]  H. Barth,et al.  The cytotoxic effect of Clostridioides difficile pore-forming toxin CDTb. , 2021, Biochimica et biophysica acta. Biomembranes.

[3]  W. Petri,et al.  Clostridium difficile binary toxin (CDT) is recognized by the TLR2/6 heterodimer to induce an NF-κB response , 2020, bioRxiv.

[4]  P. Klenerman,et al.  Human MAIT Cell Activation In Vitro. , 2020, Methods in molecular biology.

[5]  J. McCormick,et al.  MAIT Cells Are Major Contributors to the Cytokine Response in Group A Streptococcal Toxic Shock Syndrome , 2019, Proceedings of the National Academy of Sciences.

[6]  S. Gong,et al.  Activation-Induced Cell Death of Mucosal-Associated Invariant T Cells Is Amplified by OX40 in Type 2 Diabetic Patients , 2019, The Journal of Immunology.

[7]  A. Lo Vecchio,et al.  Differential effects of Clostridium difficile toxins on ion secretion and cell integrity in human intestinal cells , 2019, Pediatric Research.

[8]  T. Vanden Berghe,et al.  Apoptosis of intestinal epithelial cells restricts Clostridium difficile infection in a model of pseudomembranous colitis , 2018, Nature Communications.

[9]  F. Klawonn,et al.  Clostridioides difficile Activates Human Mucosal-Associated Invariant T Cells , 2018, Front. Microbiol..

[10]  M. Hust,et al.  The Binary Toxin CDT of Clostridium difficile as a Tool for Intracellular Delivery of Bacterial Glucosyltransferase Domains , 2018, Toxins.

[11]  H. Liesegang,et al.  High metabolic versatility of different toxigenic and non-toxigenic Clostridioides difficile isolates. , 2017, International journal of medical microbiology : IJMM.

[12]  K. Garey,et al.  Cytokines Are Markers of the Clostridium difficile-Induced Inflammatory Response and Predict Disease Severity , 2017, Clinical and Vaccine Immunology.

[13]  J. McCluskey,et al.  MAIT cells launch a rapid, robust and distinct hyperinflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: Defining a novel mechanism of superantigen-induced immunopathology and immunosuppression , 2017, PLoS biology.

[14]  V. Narang,et al.  Functionally diverse human T cells recognize non-microbial antigens presented by MR1 , 2017, eLife.

[15]  J. McCluskey,et al.  Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells , 2017, Nature Immunology.

[16]  M. A. Farrow,et al.  Clostridium difficile Toxins TcdA and TcdB Cause Colonic Tissue Damage by Distinct Mechanisms , 2016, Infection and Immunity.

[17]  W. Petri,et al.  The binary toxin CDT enhances Clostridium difficile virulence by suppressing protective colonic eosinophilia , 2016, Nature Microbiology.

[18]  W. Petri,et al.  Glucosylation Drives the Innate Inflammatory Response to Clostridium difficile Toxin A , 2016, Infection and Immunity.

[19]  P. Klenerman,et al.  TLR signaling in human antigen‐presenting cells regulates MR1‐dependent activation of MAIT cells , 2016, European journal of immunology.

[20]  D. Schomburg,et al.  Time-resolved amino acid uptake of Clostridium difficile 630Δerm and concomitant fermentation product and toxin formation , 2015, BMC Microbiology.

[21]  D. Aronoff,et al.  Identification of Toxemia in Patients with Clostridium difficile Infection , 2015, PloS one.

[22]  P. Klenerman,et al.  MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets , 2014, Mucosal Immunology.

[23]  James McCluskey,et al.  A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells , 2014, The Journal of experimental medicine.

[24]  D. Sinderen,et al.  T-cell activation by transitory neo-antigens derived from distinct microbial pathways , 2014, Nature.

[25]  M. Soriani,et al.  Clostridium difficile toxins facilitate bacterial colonization by modulating the fence and gate function of colonic epithelium. , 2014, The Journal of infectious diseases.

[26]  H. Stahlberg,et al.  Clostridium difficile toxin CDT hijacks microtubule organization and reroutes vesicle traffic to increase pathogen adherence , 2014, Proceedings of the National Academy of Sciences.

[27]  P. Klenerman,et al.  CD161++CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner , 2013, European journal of immunology.

[28]  P. Rutgeerts,et al.  999 In Vitro and In Vivo Characterization of Neutralizing Monoclonal Antibodies Against Clostridium difficile Toxins a and B , 2013 .

[29]  Saravanan Nandagopal,et al.  Effects of Clostridium difficile Toxin A and B on Human T Lymphocyte Migration , 2013, Toxins.

[30]  B. Gazzard,et al.  Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. , 2013, Blood.

[31]  M. Pirmohamed,et al.  Emergence and global spread of epidemic healthcare-associated Clostridium difficile , 2012, Nature Genetics.

[32]  Malcolm J. McConville,et al.  MR1 presents microbial vitamin B metabolites to MAIT cells , 2012, Nature.

[33]  S. Tzipori,et al.  Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models. , 2012, The Journal of infectious diseases.

[34]  H. Sasaki,et al.  LSR defines cell corners for tricellular tight junction formation in epithelial cells , 2011, Journal of Cell Science.

[35]  O. Lantz,et al.  Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. , 2011, Blood.

[36]  K. Mølbak,et al.  Binary toxin and death after Clostridium difficile infection. , 2011, Emerging infectious diseases.

[37]  C. Stratton,et al.  Assessment of Clostridium difficile Infections by Quantitative Detection of tcdB Toxin by Use of a Real-Time Cell Analysis System , 2010, Journal of Clinical Microbiology.

[38]  O. Lantz,et al.  Antimicrobial activity of mucosal-associated invariant T cells , 2010, Nature Immunology.

[39]  L. Gonzales.  Clostridium difficile , 2010, Methods in Molecular Biology™.

[40]  J. Wehland,et al.  Clostridium difficile Toxin CDT Induces Formation of Microtubule-Based Protrusions and Increases Adherence of Bacteria , 2009, PLoS pathogens.

[41]  D. Fremont,et al.  MR1 antigen presentation to mucosal-associated invariant T cells was highly conserved in evolution , 2009, Proceedings of the National Academy of Sciences.

[42]  O. Lantz,et al.  Stepwise Development of MAIT Cells in Mouse and Human , 2009, PLoS biology.

[43]  Hong Gyu Park,et al.  Clostridium difficile toxin A promotes dendritic cell maturation and chemokine CXCL2 expression through p38, IKK, and the NF-κB signaling pathway , 2009, Journal of Molecular Medicine.

[44]  J. Mossong,et al.  Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. , 2008, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[45]  I. Just,et al.  Expression of recombinant Clostridium difficile toxin A using the Bacillus megaterium system. , 2003, Biochemical and biophysical research communications.

[46]  Olivier Lantz,et al.  Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1 , 2003, Nature.

[47]  K. Aktories,et al.  Characterization of the Enzymatic Component of the ADP-Ribosyltransferase Toxin CDTa from Clostridium difficile , 2001, Infection and Immunity.

[48]  S. Erlandsen,et al.  Clostridium difficile toxins A and B can alter epithelial permeability and promote bacterial paracellular migration through HT-29 enterocytes. , 2000, Shock.

[49]  M. Bonneville,et al.  An Invariant T Cell Receptor α Chain Defines a Novel TAP-independent Major Histocompatibility Complex Class Ib–restricted α/β T Cell Subpopulation in Mammals , 1999, The Journal of experimental medicine.

[50]  R. Guerrant,et al.  Clostridium difficile toxin A induces the release of neutrophil chemotactic factors from rat peritoneal macrophages: role of interleukin-1beta, tumor necrosis factor alpha, and leukotrienes , 1997, Infection and immunity.

[51]  F. Cunha,et al.  The involvement of macrophage‐derived tumour necrosis factor and lipoxygenase products on the neutrophil recruitment induced by Clostridium difficile toxin B , 1997, Immunology.

[52]  C. Pothoulakis,et al.  Pathogenesis of Clostridium difficile-associated diarrhoea. , 1996, European journal of gastroenterology & hepatology.

[53]  T. Gray,et al.  Effect of Clostridium difficile toxin A on human intestinal epithelial cells: induction of interleukin 8 production and apoptosis after cell detachment. , 1996, Gut.

[54]  M. Wilm,et al.  The Enterotoxin from Clostridium difficile (ToxA) Monoglucosylates the Rho Proteins(*) , 1995, The Journal of Biological Chemistry.

[55]  M. Mann,et al.  Glucosylation of Rho proteins by Clostridium difficile toxin B , 1995, Nature.

[56]  C. Pothoulakis,et al.  Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes. , 1988, The Journal of clinical investigation.